Microsoft Word 88 Hemofiliya

Antimicrob Chemother 2008; 61(6):1191-200. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/18356154?dopt=Abstract  (20.10.2014) 

24.

 

Frachon X, Pommereuil M, Berthier AM, et al. Management options 

for dental extraction in hemophiliacs: a study of 55 extractions (2000-

2002). [Electronic resource]. Oral Surg Oral Med Oral Pathol Oral 

Radiol Endod 2005; 99(3):270-5. - Available at:  

 

 

 

 

 

 

Klinik protokol Az

ərbaycan Respublikas

ı S

əhiyy

ə Nazirliyinin 

İctimai S

əhi

yy

ə v

ə 

İslahatlar M

ərk

əzind

ə haz

ırlanm

ış

dı

r. 

---

56 

http://www.ncbi.nlm.nih.gov/pubmed/15716831?dopt=Abstract  (20.10.2014) 

25.

 

Gomis M, Querol F, Gallach JE, Gonzalez LM, Aznar JA. Exercise and 

sport in the treatment of haemophilic patients: a systematic review. 

[Electronic resource]. Haemophilia 2009; 15(1):43-54.- Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/18721151?dopt=Abstract  (20.10.2014) 

26.

 

Giangrande PL, Wilde JT, Madan B, et al. Consensus protocol for the 

use of recombinant activated factor VII in elective orthopaedic surgery 

in haemophilic patients with inhibitors. [Electronic resource]. 

Haemophilia 2009; 15(2):501-8. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/19187194?dopt=Abstract  (20.10.2014) 

27.

 

Gringeri A, Lundin B, Mackensen SV, et al. A randomized clinical trial 

of prophylaxis in children with hemophilia A (the ESPRIT Study). 

[Electronic resource]. J Thromb Haemost 2011; 9(4):700-10. - 

Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/21255253?dopt=Abstract  (20.10.2014) 

28.

 

Guidelines for the management of hemophilia. [Electronic resource]. 

2nd edition. 2012.- Available at: www.WFH.org (20.10.2014) 

29.

 

Hartwell D, Jones J, Baxter L, Shepherd J. Peginterferon alfa and 

ribavirin for chronic hepatitis C in patients eligible for shortened 

treatment, re-treatment or in HCV/HIV co-infection: a systematic 

review and economic evaluation. [Electronic resource]. Health Technol 

Assess 2011 Apr; 15(17):i-xii, 1-210.  - Available  at:  

http://www.ncbi.nlm.nih.gov/pubmed/21473834?dopt=Abstract (20.10.2014) 

30.

 

Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis 

and management of factor VIII and IX inhibitors: a guideline from the 

United Kingdom Haemophilia Centre Doctors Organisation. [Electronic 

resource]. Br J Haematol 2006; 133:591-605. - Available at:  

http://www.ncbi.nlm.nih.gov/pubmed/16704433?dopt=Abstract  (20.10.2014) 

31.

 

Hermans C, de Moerloose P, Fischer K, Holstein K, Klamroth R, 

Lambert T, et al; European Haemophilia Therapy Standardisation 

Board. Management of acute haemarthrosis in haemophilia A without 

inhibitors: literature review, European survey and recommendations. 

[Electronic resource]. Haemophilia 2011; 17(3):383-92. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/21323794?dopt=Abstract  (20.10.2014) 

32.

 

Hermans C, Altisent C, Batorova A, et al.; European Haemophilia 

Therapy Standardisation Board. Replacement therapy for invasive 

procedures in patients with haemophilia: literature review, European 

 

 

 

 

 

 

Klinik protokol Az

ərbaycan Respublikas

ı S

əhiyy

ə Nazirliyinin 

İctimai S

əhi

yy

ə v

ə 

İslahatlar M

ərk

əzind

ə haz

ırlanm

ış

dı

r. 

---

57 

survey and recommendations. [Electronic resource]. Haemophilia 

2009; 15(3):639-58. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/19444969?dopt=Abstract (20.10.2014) 

33.

 

Hewson I, Makhmalbaf P, Street A, et al. Dental surgery with minimal 

factor support in the inherited bleeding disorder population at the 

Alfred Hospital. [Electronic resource]. Haemophilia 2011; 17(1):e185-

8. - Available at: 

http://www.ncbi.nlm.nih.gov/pubmed/20557354?dopt=Abstract  (20.10.2014) 

34.

 

Hvas AM, Sorensen HT, Norengaard L, et al. Tranexamic acid 

combined with recombinant factor VIII increases clot resistance to 

accelerated fibrinolysis in severe hemophilia A. [Electronic resource]. J